There has been substantial investment and commercial scale-up of circulating tumor DNA technologies, indicating the field is moving rapidly from research methods (4 years ago) to clinically deployed and commercialized applications.

factualpending

Speaker

Unknown Speaker (Oncologist)

Evidence Quote

“there's been a real explosion in terms of investment in this area and now scale up of technologies that are you know commercially relevant”

Source

How early cancer screening can save lives | Peter Attia & Keith Flaherty— Peter Attia MD
Created: 8/11/2026, 1:43:50 AM

Your notes

Loading notes...